3
088 J . Org. Chem., Vol. 66, No. 9, 2001
Bozell et al.
before use. Other solvents were reagent grade and used
without further purification unless otherwise noted. Noncom-
mercial cinnamates and all diols were prepared according to
NMR (11c): 1.16 (t, J ) 7.2 Hz, 3H), 3.74 (br s, 1H), 3.76 (s,
3H), 4.12 (q, J ) 7.2 Hz, 2H), 4.34 (d, J ) 4.1 Hz, 1H), 4.82
(br t, J ) 4.1 Hz, 1H), 5.48 (br s, 1H), 6.59 (s, 1H), 6.75-6.81
literature methods.16,17 BF
‚OEt
was distilled under an inert
(m, 2H), 7.15-7.20 (m, 3H). C NMR 14.0, 52.7, 55.1, 61.8,
13
3
2
atmosphere and stored under argon. All other materials were
commercially available and used as received.
73.7, 113.7, 115.2, 129.4, 130.2, 131.1, 133.6, 154.7, 158.1,
173.9; IR: 3450, 2968, 2861, 1734, 1609, 1050, 1116. MS m/z
calcd 316.1311, found 316.1296.
E t h yl-2-a cet oxy-3,3-d i-(4-m et h oxyp h en yl)p r op ion a t e
(12a ). Ortho ester 8a (701 mg, 2.37 mmol) was treated with
Gen er a l P r oced u r e for t h e P r ep a r a t ion of Or t h o
Ester s. A mixture of the diol (1 mmol) and trimethylortho-
acetate (1.5 mmol) was dissolved in THF (10 mL). The solution
was degassed and taken to -20 °C. It was treated with a
solution (2 mg/mL) of p-TsOH in THF to give a catalyst level
of 0.2-0.5 mol %. The reaction was stirred at -20 °C until
complete as indicated by TLC (usually 30-60 min). The
anisole (256 mg, 2.37 mmol, 257 µL, F ) 0.995) and BF
3
‚OEt
2
(874 µL, 7.1 mmol) according to the general procedure. Normal
workup and purification on silica gel (5:1 hexane/EtOAc) gave
429 mg (49%) of 12a as a white solid, mp 83.5-84.5 °C. Also
isolated was 141 mg (16%) of the corresponding deacylated
reaction was quenched by the addition of saturated NaHCO
50-75 µL). The solvent was removed on the rotary evaporator.
The residue was purified by rapid filtration through a 2.5 × 5
cm bed of silica gel using 1:1 hexane/Et O as the eluent.
3
1
(
product 12c as a clear oil. H NMR (12a ): 1.00 (t, J ) 7.1 Hz,
3H), 2.04 (s, 3H), 3.75 (s, 3H), 3.77 (s, 3H), 3.98 (br q, J ) 7.1
Hz, 2H), 4.49 (d, J ) 7.1 Hz, 1H), 5.64 (d, J ) 7.1 Hz, 1H),
6.82 (m, 4H), 7.19 (m, 4H). 13C NMR: 13.8, 20.6, 50.8, 55.1,
61.2, 74.9, 113.8, 129.4, 129.7, 131.7, 132.0, 158.4, 169.2, 170.3.
IR: 2975, 2834, 1758, 1610, 1521, 1461, 1380, 1250, 1031, 828.
2
Solvent removal gave the ortho ester as a clear oil. The ortho
esters were normally used immediately after preparation. The
1
H NMR spectrum for ortho ester 8b is typical for the
diastereomeric mixture obtained: 1.3 (overlapping t, 3H), 1.70
26 7
Anal. Calcd for C22H O : C, 67.73; H, 6.50; O, 25.78. Found:
1
(s, 3H), 1.75 (s, 3H), 3.40 (s, 3H), 3.43 (s, 3H), 4.25 (overlapping
C, 67.66; H, 6.72; O, 25.62. H NMR (12c): 1.30 (t, J ) 7.0
Hz, 3H), 2.98 (br s, 1H), 3.87 (s, 3H), 3.88 (s, 3H), 4.25 (q, J )
7.0 Hz, 2H), 4.50 (d, J ) 3.9 Hz, 1H), 4.95 (br d, J ) 3.9 Hz,
1H), 6.90-6.97 (m, 4H), 7.27-7.32 (m, 4H), 7.40-7.45 (m, 4H).
m, 2H), 4.40 and 5.35 (dd, 2H), 4.44 and 5.10 (dd, 2H), 7.28-
7
.47 (m, 5H).
Gen er a l P r oced u r e for Or th o Ester Ar yla tion . The
1
3
ortho ester and phenol (1:1 molar ratio) were dissolved in
freshly distilled THF (10-15 mL/mmol). The solution was
cooled to -78 °C and stirred for 5 min. It was treated with
C NMR: 14.0, 52.6, 55.1, 61.6, 73.6, 113.6, 129.4, 130.2,
133.7, 158.4, 158.8, 173.7. IR: 3489, 2965, 2839, 1745, 1619,
1516, 1464, 1250, 1031, 734. MS m/z calcd 330.1467, found
330.1458.
Eth yl-2-a cetoxy-3-(3,4-m eth ylen ed ioxyp h en yl)-3-(3-h y-
dr oxy-4-m eth oxy-6-m eth ylph en yl)pr opion ate (13a). Ortho
ester 8c (607 mg, 1.96 mmol) was treated with methyl guaiacol
BF
reaction was warmed to -20 °C and stirred for 72 h. It was
quenched by the addition of saturated NaHCO (1 mL). The
3
‚OEt
2
(3 mmol) and stirred for 60 min at -78 °C. The
3
solvent was removed on the rotary evaporator, and the residue
was purified by column chromatography on silica gel using a
variety of solvent systems. When necessary, samples for
analysis were further purified by recrystallization at -20 °C
(9) (405 mg, 2.94 mmol, 303 µL, F ) 1.092) and BF
3
‚OEt
2
according to the general procedure. Normal workup and
purification on silica gel (4:1 hexane/EtOAc) gave 433 mg (53%)
1
from mixtures of Et
2
O/hexane.
of 13a as a white solid, mp 48.5-49.5 °C. H NMR: 1.10 (t, J
C-Ad d it ion P r od u ct s. E t h yl-2-a cet oxy-3-(4-m et h oxy-
phenyl)-3-(3-hydroxy-4-methoxy-6-methylphenyl)propionate
) 7.5 Hz, 3H), 2.15 (s, 3H), 2.25 (s, 3H), 3.94 (s, 3H), 4.08 (m,
2H), 4.68 (d, J ) 7.7 Hz, 1H), 5.58 (br s, 1H), 5.63 (d, J ) 7.8
1
3
(
10a ). Ortho ester 8a (710 mg, 2.4 mmol) was treated with
methyl guaiacol (9) (331 mg, 2.4 mmol, 303 µL, F ) 1.092) and
BF ‚OEt (886 µL, 7.2 mmol) according to the general proce-
Hz, 1H), 5.99 (dd, J ) 7.6, 1.9 Hz, 2H), 6.59-6.82 (m, 5H). C
NMR: 13.7, 19.4, 20.6, 47.5, 55.8, 61.1, 75.2, 100.9, 108.0,
109.3, 113.2, 113.4, 122.2, 128.3, 130.3, 132.5, 143.4, 145.0,
146.4, 147.6, 169.4, 170.3. IR: 3460, 2934, 1743, 1591, 1515,
3
2
dure. Normal workup and purification on silica gel (5:1 hexane/
EtOAc to 2:1 EtOAc/hexane) gave 570 mg (60%) of 10a as a
white solid, mp 147.5-148.5 °C. Also isolated was 200 mg
1438, 1376, 1234. Anal. Calcd for C22
24 8
H O : C, 63.45; H, 5.81;
O, 30.74. Found: C, 63.57; H, 5.66; O, 30.77.
(
1
3
21%) of the corresponding deacylated product 10c, mp 113.5-
E t h yl-2-a cet oxy-3-p h en yl-3-(3-h yd r oxy-4-m et h oxy-6-
m eth ylp h en yl)p r op ion a te (14a ). Ortho ester 8b (601 mg,
2.26 mmol) was treated with methyl guaiacol (9) (312 mg, 2.26
1
14.5 °C. H NMR (10a ): 0.93 (t, J ) 7.0 Hz, 3H), 2.02 (s,
H), 2.12 (s, 3H), 3.72 (s, 3H), 3.81 (s, 3H), 3.92 (m, 2H), 4.58
(
(
2
1
2
d, J ) 8.2 Hz, 1H), 5.49 (s, 1H), 5.53 (d, J ) 8.2 Hz, 1H), 6.59
mmol, 286 µL, F ) 1.092) and BF
according to the general procedure. Normal workup and
purification on silica gel (3:2 Et O/hexane) gave 152 mg (18%)
3
‚OEt
2
(833 µL, 6.77 mmol)
s, 1H), 6.75 (m, 2H), 7.06-7.12 (m, 3H). 1 C NMR: 13.6, 19.3,
3
0.6, 47.1, 55.1, 55.8, 61.1, 75.2, 113.2, 113.4, 113.7, 128.2,
29.8, 130.5, 130.7, 143.4, 144.8, 158.4, 169.5, 170.4; IR: 3441,
979, 2848, 1738, 1614, 1517, 1469, 1250, 1055, 832. Anal.
2
1
of 14a as a white solid, mp 103-104 °C. H NMR: 0.98 (t, J
) 7.0 Hz, 3H), 2.01 (s, 3H), 2.28 (s, 3H), 3.80 (s, 3H), 3.99 (m,
2H), 4.72 (d, J ) 7.6 Hz, 1H), 5.36 (s, 1H), 5.60 (d, J ) 7.6 Hz,
Calcd for C22
6
3
26 7
H O : C, 65.66; H, 6.51; O, 27.83. Found: C,
1
13
5.79; H, 6.55; O, 27.66. H NMR (10c): 1.04 (t, J ) 7.2 Hz,
1H), 6.58 (s, 1H), 6.82 (s, 1H), 7.13-7.29 (m, 5H). C NMR:
H), 2.16 (s, 3H), 3.74 (s, 3H), 3.80 (s, 3H), 4.02 (m, 2H), 4.44
13.7, 19.5, 20.6, 47.5, 55.8, 61.2, 74.3, 112.8, 115.0, 126.7, 127.3,
128.3, 128.6, 130.5, 139.6, 143.4, 145.1, 169.4, 170.2. IR: 3531,
3447, 2978, 1751, 1519, 1378, 1264, 1205, 1037. Anal. Calcd
(
d, J ) 6.2 Hz, 1H), 4.76 (br m, 1H), 5.48 (br s, 1H), 6.59 (s,
1
1
1
2
H), 6.75-6.81 (m, 2H), 7.15-7.20 (m, 3H). 13C NMR: 13.8,
9.3, 49.1, 55.2, 55.8, 61.4, 74.1, 113.1, 113.7, 114.4, 128.1,
29.6, 130.7, 132.5, 143.4, 144.9, 158.2, 173.7; IR: 3518, 3473,
953, 2842, 1729, 1617, 1513, 1461, 1250, 1093, 781. Anal.
for C21
24 6
H O : C, 67.73; H, 6.50; O, 25.78. Found: C, 67.68; H,
6.44; O, 25.88.
Eth yl-2-acetoxy-3-ph en yl-3-(3-h ydr oxy-4-m eth oxyph en -
yl)p r op ion a te (15a ). Ortho ester 8b (601 mg, 2.26 mmol) was
treated with guaiacol (336 mg, 2.7 mmol, 297 µL, F ) 1.129)
Calcd for C20
6.67; H, 6.71; O, 26.62.
Eth yl-2-acetoxy-3-(4-m eth oxyph en yl)-3-(4-h ydr oxyph en -
yl)p r op ion a te (11a ). Ortho ester 8a (585 mg, 1.97 mmol) was
treated with phenol (187 mg, 1.97 mmol) and BF ‚OEt
according to the general procedure. Normal workup and
purification on silica gel (3:2 hexane/Et O) gave 254 mg (36%)
of 11a as a white solid, mp 109.5-110.5 °C. Also isolated was
4 mg (12%) of the corresponding deacylated product 11c as
24 6
H O : C, 66.65; H, 6.71; O, 26.64. Found: C,
6
and BF
3
‚OEt (833 µL, 6.77 mmol) according to the general
2
procedure. Normal workup and purification on silica gel (3:2
Et O/hexane) gave 156 mg (19%) of 15a as a clear oil. H
2
1
3
2
NMR: 0.98 (t, 3H), 2.2 (s, 3H), 3.78 (s, 3H), 3.92-4.0 (m, 2H),
2
4.47-4.51 (d, J ) 8.3 Hz, 1H), 5.59 (s, 1H), 5.64-5.68 (d, J )
1
3
10.4 Hz, 1H), 6.68-6.8 (m, 3H), 7.19-7.34 (m, 5H). C NMR:
13.7, 20.5, 52.1, 55.8, 61.2, 74.7, 111.1, 114.2, 121.4, 126.9,
128.4, 128.5, 131.3, 139.6, 144.7, 146.3, 169.2, 170.3. IR: 3451,
2977, 2839, 1742, 1598, 1511, 1442, 1374. Anal. Calcd for
8
1
a clear oil. H NMR (11a ): 0.99 (t, J ) 7.0 Hz, 3H), 2.02 (s,
3
H), 3.75 (s, 3H), 3.98 (m, 2H), 4.45 (d, J ) 6.5 Hz, 1H), 5.62
1
3
(m, 1H), 6.60-6.80 (m, 4H), 7.05-7.24 (m, 4H). C NMR: 13.8,
C
20
H
22
O
6
: C, 67.03; H, 6.19; O, 26.79. Found: C, 67.12; H, 6.32;
2
1
1
0.6, 50.8, 55.2, 61.4, 74.9, 113.8, 115.3, 129.4, 129.6, 129.9,
31.4, 132.0, 154.8, 158.5, 169.5, 170.6; IR: 3405, 2927, 2833,
O, 26.56.
O-Ad d it ion P r od u ct s. E t h yl-2-a cet oxy-3-p h en yl-3-(2-
m eth oxy-4-m eth ylp h en oxy)p r op ion a te (14b). Ortho ester
1
761, 1250, 1030. MS m/z calcd 358.1416, found 358.1403. H